A critical discovery in cancer study is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential cancer inhibitor protein is frequently disabled in several kinds of cancer, resulting https://modernbookmarks.com/story21719341/mini-antibodies-restore-tumor-suppressor-p53-new-promising-hope-for-tumor-therapy